Very interestingly, chronic enzalutamide treatment leads to GR upregulation, which replaces AR to transcriptionally regulate AR targeting genes for the survival of enzalutamide-resistant PCa, a new mechanism for PCa cells to escape AR inhibition [164]. Here, NR3C1 is linked to posterior cortical atrophy.